comparemela.com

Latest Breaking News On - Elsevier ltd - Page 38 : comparemela.com

Pirfenidone in rheumatoid arthritis-associated interstitial lung disease – Authors reply

Regarding the forced vital capacity (FVC) and percent predicted FVC (FVC%) secondary outcomes in our TRAIL1 study,1 we wish to clarify the perceived inconsistency between the statistical model results and the raw data summaries, particularly for usual interstitial pneumonia. Although outcomes were secondary and subgroup analyses were not pre-planned, the statistical model estimated larger declines in placebo compared with pirfenidone for FVC and FVC%, a pattern not visually apparent in the raw data plots.

Concerns regarding a suggested long COVID paradigm – Authors reply

We thank the authors of these three helpful responses to our previously published Comment.1 We welcome Fabian Schwendinger and colleagues highlighting some important factors related to the ongoing immune response that we did not expand upon and for introducing the microbiome. Knowing which factors are necessary and sufficient to understand and treat long COVID (also known as post-COVID-19 condition) across the spectrum is an important goal of a research programme. An exploratory model is needed as the starting point of such a research programme, but scientific models are updated as research progresses.

Respiratory syncytial virus-induced disease in healthy infants: we need to offload this burden

In the slipstream of the extraordinary, worldwide natural experiment reducing close human contact to mitigate the spread of SARS-CoV-2, a drastically but temporarily diminished transmission of respiratory syncytial virus (RSV) in children occurred in the winter of 2020–21.1 This glimpse of a world without RSV gained momentum for the urgent need for preventive strategies for this prototypical paediatric pathogen, which causes a spectrum of mild upper-respiratory to severe lower-respiratory tract disease in young children.

Concerns regarding a suggested long COVID paradigm

Upon reading Chloe Saunders and colleagues’ Comment,1 it is striking how this new paradigm is essentially the old paradigm for medically unexplained symptoms and contested illnesses.2 The authors advance an alleged philosophical problem they call “taboos based on a dualistic understanding of physical versus mental illness”. They assert such “Poorly integrated explanatory models contribute to poor care and stigma for people who are ill in these specific ways.”

Concerns regarding a suggested long COVID paradigm

Concerns regarding a suggested long COVID paradigm
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.